---
title: blog | Braveheart Bio
description: Braveheart Bio |
---

[Skip to content](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/braveheart-bio#main-content)

[![IPO\_PROPHET\_BLUE logo](https://blog.ipoprophet.com/hs-fs/hubfs/IPO_PROPHET_BLUE%20logo.png?width=2973&height=302&name=IPO_PROPHET_BLUE%20logo.png)](https://www.IPOProphet.com)

- [Login](https://app.ipoprophet.com/login)

Open main navigation

Close main navigation

- [Login](https://app.ipoprophet.com/login)

[Subscribe to our Newsletter](https://share.hsforms.com/1xXldKrGiQBCbNmtOz6j4Jwq3cu4)

[Go Back to Home](http://www.ipoprophet.com/)

[Go Back to Blog](http://www.ipoprophet.com/blog)

[![](https://blog.ipoprophet.com/hubfs/Braveheart%20Bio%20Logo-1.png)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/braveheart-bio-brve-surges-66-in-ipo-debut-as-investors-embrace-precision-cardiovascular-medicine)

[IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Braveheart Bio](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/braveheart-bio)

## [Braveheart Bio (BRVE) Surges 66% in IPO Debut as Investors Embrace Precision Cardiovascular Medicine](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/braveheart-bio-brve-surges-66-in-ipo-debut-as-investors-embrace-precision-cardiovascular-medicine)

![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) 

 Aug 6, 2026, 4:29:40 PM

Braveheart Bio, Inc. (NASDAQ: BRVE) delivered one of the strongest biotechnology IPO performances of...

[![](https://blog.ipoprophet.com/hubfs/Braveheart%20Bio%20Thumbnail.jpg)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/braveheart-bio-brve-sets-terms-for-300-million-ipo-to-advance-next-generation-therapy-for-hypertrophic-cardiomyopathy)

[IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Braveheart Bio](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/braveheart-bio)

## [Braveheart Bio (BRVE) Sets Terms for $300 Million IPO to Advance Next-Generation Therapy for Hypertrophic Cardiomyopathy](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/braveheart-bio-brve-sets-terms-for-300-million-ipo-to-advance-next-generation-therapy-for-hypertrophic-cardiomyopathy)

![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) 

 Jul 31, 2026, 1:41:24 PM

Braveheart Bio (NASDAQ: BRVE) has filed to raise approximately $300 million through an initial publi...

### Subscribe to our Newsletter

 Email

[linkedin-in icon](https://www.linkedin.com/company/ipo-prophet-software/) [X Twitter icon](https://www.x.com/ipoprophet)

---

[![IPO\_PROPHET\_WHITE-2](https://blog.ipoprophet.com/hs-fs/hubfs/IPO_PROPHET_WHITE-2.png?width=800&height=250&name=IPO_PROPHET_WHITE-2.png "IPO_PROPHET_WHITE-2")](http://www.ipoprophet.com)

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.

Copyright © 2025